Erratum: Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme (European Journal of Nuclear Medicine and Molecular Imaging (2010) 37 (84-92) DOI: 10.1007/s00259-009-1219-5));Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 1, 2010, Pages 84-92

  Galldiks, Norbert ^a   Ullrich, Roland ^b   Schroeter, Michael ^a   Fink, Gereon R ^a   Kracht, Lutz W ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

Active tumour volume; Gd DTPA enhancement; Patient tailored therapy; Three dimensional assessment; Volume of interest (VOI) analysis

Indexed keywords

GADOLINIUM PENTETATE; METHIONINE C 11; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; VOLUMETRY;

EID: 72949111978     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1509-y     Document Type: Erratum

References (30)

1. JM Nazzaro EA Neuwelt 1990 The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults J Neurosurg 73 331 344 10.3171/jns.1990.73.3.0331 1:STN:280:DyaK3czkslGjtg%3D%3D 2166779
2. EC Halperin G Bentel ER Heinz PC Burger 1989 Radiation therapy treatment planning in supratentorial glioblastoma multiforme: an analysis based on post mortem topographic anatomy with CT correlations Int J Radiat Oncol Biol Phys 17 1347 1350 1:STN:280:DyaK3c%2Fptl2hsQ%3D%3D 2557310
3. LD Lunsford AJ Martinez RE Latchaw 1986 Magnetic resonance imaging does not define tumor boundaries Acta Radiol Suppl 369 154 156 1:STN:280: DyaK383jvVWntA%3D%3D 2980437
4. M Levivier A Becerra O De Witte J Brotchi S Goldman 1996 Radiation necrosis or recurrence J Neurosurg 84 148 149 1:STN:280:DyaK287htVyguw%3D%3D 8613825
5. JG Cairncross DR Macdonald JH Pexman FJ Ives 1988 Steroid-induced CT changes in patients with recurrent malignant glioma Neurology 38 724 726 1:STN:280:DyaL1c3gt1Ciuw%3D%3D 3362369
6. L Ostergaard FH Hochberg JD Rabinov AG Sorensen M Lev L Kim, et al. 1999 Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors J Neurosurg 90 300 305 10.3171/jns.1999.90.2.0300 1:STN:280:DyaK1M7jsVSjsg%3D%3D 9950501
7. LW Kracht H Miletic S Busch AH Jacobs J Voges M Hoevels, et al. 2004 Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology Clin Cancer Res 10 7163 7170 10.1158/1078-0432.CCR-04-0262 1:CAS:528:DC%2BD2cXpsVKltLY%3D 15534088 (Pubitemid 39487701)
8. K Herholz T Holzer B Bauer R Schroder J Voges RI Ernestus, et al. 1998 11C-methionine PET for differential diagnosis of low-grade gliomas Neurology 50 1316 1322 1:STN:280:DyaK1c3lsFCiuw%3D%3D 9595980
9. MJ Reinhardt K Kubota S Yamada R Iwata H Yaegashi 1997 Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine J Nucl Med 38 280 287 1:CAS:528:DyaK2sXhsFSrsrw%3D 9025756
10. Y Sonoda T Kumabe T Takahashi R Shirane T Yoshimoto 1998 Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis Neurol Med Chir (Tokyo) 38 342 347 10.2176/nmc.38.342 1:STN:280:DyaK1czlsVansA%3D%3D
11. DK Kim Y Kanai HW Choi S Tangtrongsup A Chairoungdua E Babu, et al. 2002 Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells Biochim Biophys Acta 1565 112 121 10.1016/S0005-2736(02)00516-3 1:CAS:528:DC%2BD38XmvVahu70%3D 12225859 (Pubitemid 35239839)
12. PL Jager W Vaalburg J Pruim EG de Vries KJ Langen DA Piers 2001 Radiolabeled amino acids: basic aspects and clinical applications in oncology J Nucl Med 42 432 445 1:CAS:528:DC%2BD3MXmvFOqt7k%3D 11337520
13. P Bustany M Chatel JM Derlon F Darcel P Sgouropoulos F Soussaline, et al. 1986 Brain tumor protein synthesis and histological grades: a study by positron emission tomography (PET) with C11-L-methionine J Neurooncol 3 397 404 10.1007/BF00165590 1:CAS:528:DyaL28XhsVGjur4%3D 3485705
14. M Bergstrom VP Collins E Ehrin K Ericson L Eriksson T Greitz, et al. 1983 Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine J Comput Assist Tomogr 7 1062 1066 10.1097/00004728-198302000-00166 1:STN:280:DyaL2c%2FjtlCksw%3D%3D 6415134
15. M Tovi A Lilja M Bergstrom A Ericsson K Bergstrom M Hartman 1990 Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography Acta Radiol 31 417 429 10.3109/02841859009173067 1:STN:280:DyaK3M%2FosVWktQ%3D%3D 2261284
16. K Miwa J Shinoda H Yano A Okumura T Iwama T Nakashima, et al. 2004 Discrepancy between lesion distributions on methionine PET and MR images in patients with glioblastoma multiforme: insight from a PET and MR fusion image study J Neurol Neurosurg Psychiatry 75 1457 1462 10.1136/jnnp.2003.028480 1:STN:280:DC%2BD2cvmslGrtw%3D%3D 15377696 (Pubitemid 39279817)
17. B Pirotte S Goldman O Dewitte N Massager D Wikler F Lefranc, et al. 2006 Integrated positron emission tomography and magnetic resonance imaging-guided resection of brain tumors: a report of 103 consecutive procedures J Neurosurg 104 238 253 10.3171/jns.2006.104.2.238 16509498
18. AL Grosu WA Weber E Riedel B Jeremic C Nieder M Franz, et al. 2005 L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy Int J Radiat Oncol Biol Phys 63 64 74 1:CAS:528:DC%2BD2MXos1ajsro%3D 16111573
19. V Braun S Dempf R Weller SN Reske W Schachenmayr HP Richter 2002 Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data - results of a pilot study in 32 surgical cases Acta Neurochir (Wien) 144 777 782 10.1007/s00701-002-0942-5 1:STN:280: DC%2BD38visVaksw%3D%3D (Pubitemid 34985271)
20. R Stupp WP Mason MJ van den Bent M Weller B Fisher MJ Taphoorn, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987 996 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D 15758009 (Pubitemid 40349501)
21. DR Macdonald TL Cascino SC Schold Jr JG Cairncross 1990 Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277 1280 1:STN:280:DyaK3c3ptlyitQ%3D%3D 2358840
22. G Berger M Maziere R Knipper C Prenant D Comar 1979 Automated synthesis of 11C-labelled radiopharmaceuticals: imipramine, chlorpromazine, nicotine and methionine Int J Appl Radiat Isot 30 393 399 10.1016/0020-708X(79)90049-8 1:CAS:528:DyaE1MXlsFKrs7c%3D 478664 (Pubitemid 9238660)
23. Vollmar S, Hampl J, Kracht L, Herholz K. Integration of functional data (PET) into brain surgery planning and neuronavigation. In: Buzug TM, Holz D, Bongartz J, Kohl-Bareis M, Hartmann U, Weber S (editors) Advances in medical engineering. Berlin: Springer; 2007. p. 98-103.
24. M Kinoshita N Hashimoto T Goto T Yanagisawa Y Okita N Kagawa, et al. 2009 Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma Neuroimage 45 312 318 10.1016/j.neuroimage.2008.11.034 19111621
25. N Galldiks LW Kracht L Burghaus A Thomas AH Jacobs WD Heiss, et al. 2006 Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas Eur J Nucl Med Mol Imaging 33 516 524 10.1007/s00259-005- 0002-5 1:CAS:528:DC%2BD28XktFSqsLY%3D 16450140
26. J Cizek K Herholz S Vollmar R Schrader J Klein WD Heiss 2004 Fast and robust registration of PET and MR images of human brain Neuroimage 22 434 442 10.1016/j.neuroimage.2004.01.016 15110036 (Pubitemid 38515852)
27. KF Schmidt M Ziu NO Schmidt P Vaghasia TG Cargioli S Doshi, et al. 2004 Volume reconstruction techniques improve the correlation between histological and in vivo tumor volume measurements in mouse models of human gliomas J Neurooncol 68 207 215 10.1023/B:NEON.0000033364.43142.bf 15332323 (Pubitemid 38878254)
28. AL Grosu WA Weber ST Astner M Adam BJ Krause M Schwaiger, et al. 2006 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy Int J Radiat Oncol Biol Phys 66 339 344 1:CAS:528:DC%2BD28Xptlyqs7k%3D 16765533
29. P Mahasittiwat JE Mizoe A Hasegawa H Ishikawa K Yoshikawa H Mizuno, et al. 2008 l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy Int J Radiat Oncol Biol Phys 70 515 522 1:CAS:528:DC%2BD1cXosVGltw%3D%3D 17900820
30. BJ Pirotte M Levivier S Goldman N Massager D Wikler O Dewitte, et al. 2009 Positron emission tomography-guided volumetric resection of supratentorial high-grade gliomas: a survival analysis in 66 consecutive patients Neurosurgery 64 471 481 10.1227/01.NEU.0000338949.94496.85 19240609